Literature DB >> 23439424

Comparison of aerobic exercise intensity prescription methods in breast cancer.

Amy A Kirkham1, Kristin L Campbell, Donald C McKenzie.   

Abstract

INTRODUCTION: Exercise plays an important role in cancer rehabilitation, but a precise prescription of exercise intensity is required to maximize the benefits of this intervention. It is unknown whether different methods of prescribing aerobic exercise intensity achieve the same intensity. Breast cancer treatments may alter exercise response and thereby may affect the accuracy of these methods.
PURPOSE: The purpose of this study was to compare the accuracy and achieved intensity of four common methods of prescribing exercise intensity within and between breast cancer patients recently finished chemotherapy (n = 10), survivors finished treatment (n = 10), and healthy controls (n = 10).
METHODS: The methods compared were as follows: the American College of Sports Medicine's metabolic equation for treadmill walking (METW), heart rate reserve (HRR), direct heart rate (DIRECT HR), and RPE. The methods were used to prescribe 60% oxygen consumption reserve (VO2R) in four randomly assigned 10-min periods of treadmill walking with expired gas collection to evaluate 1) achieved intensity (measured % VO2R) and 2) accuracy (defined as: [60% VO2R-achieved intensity]).
RESULTS: The accuracy of the methods was not equivalent across groups (P = 0.04). HRR and METW did not differ across groups and were most accurate in patients. HRR, METW, and DIRECT HR were all more accurate than RPE in survivors (P ≤ 0.01). RPE was the least accurate in all groups. The accuracy of DIRECT HR was much lower in patients than that in survivors and controls (P ≤ 0.01).
CONCLUSIONS: The four methods of exercise intensity prescription varied in accuracy in prescribing 60% VO2R and did not achieve equivalent exercise intensities within breast cancer patients, survivors, and healthy controls. HRR and METW were the most accurate methods for exercise intensity prescription in breast cancer patients and survivors.

Entities:  

Mesh:

Year:  2013        PMID: 23439424     DOI: 10.1249/MSS.0b013e3182895195

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  9 in total

Review 1.  Evaluating Trastuzumab in the treatment of HER2 positive breast cancer.

Authors:  Ryan Jaques; Sam Xu; Antonios Matsakas
Journal:  Histol Histopathol       Date:  2020-04-23       Impact factor: 2.303

Review 2.  Exercise in patients coping with breast cancer: An overview.

Authors:  Sibel Eyigor; Selcen Kanyilmaz
Journal:  World J Clin Oncol       Date:  2014-08-10

3.  Reducing Metabolic Dysregulation in Obese Latina and/or Hispanic Breast Cancer Survivors Using Physical Activity (ROSA) Trial: A Study Protocol.

Authors:  Paola Gonzalo-Encabo; Rebekah L Wilson; Dong-Woo Kang; Mary K Norris; Hajime Uno; Cami N Christopher; Christina Chow; Nathalie Sami; Frank S Fox; Jennifer A Ligibel; Christina M Dieli-Conwright
Journal:  Front Oncol       Date:  2022-05-10       Impact factor: 5.738

4.  A Longitudinal Study of the Association of Clinical Indices of Cardiovascular Autonomic Function with Breast Cancer Treatment and Exercise Training.

Authors:  Amy A Kirkham; Matthew G Lloyd; Victoria E Claydon; Karen A Gelmon; Donald C McKenzie; Kristin L Campbell
Journal:  Oncologist       Date:  2018-09-26

5.  Adherence to a lower versus higher intensity physical activity intervention in the Breast Cancer & Physical Activity Level (BC-PAL) Trial.

Authors:  Jessica McNeil; Mina Fahim; Chelsea R Stone; Rachel O'Reilly; Kerry S Courneya; Christine M Friedenreich
Journal:  J Cancer Surviv       Date:  2021-03-22       Impact factor: 4.442

Review 6.  The Lactate Minimum Test: Concept, Methodological Aspects and Insights for Future Investigations in Human and Animal Models.

Authors:  Leonardo H D Messias; Claudio A Gobatto; Wladimir R Beck; Fúlvia B Manchado-Gobatto
Journal:  Front Physiol       Date:  2017-06-08       Impact factor: 4.566

7.  Impact of community-based exercise program participation on aerobic capacity in women with and without breast cancer.

Authors:  Jordan T Lee; Chad W Wagoner; Stephanie A Sullivan; Dean J Amatuli; Kirsten A Nyrop; Erik D Hanson; Lee Stoner; Brian C Jensen; Hyman B Muss; Claudio L Battaglini
Journal:  World J Clin Oncol       Date:  2021-06-24

Review 8.  New Insights into the Role of Exercise in Inhibiting mTOR Signaling in Triple-Negative Breast Cancer.

Authors:  Deborah Agostini; Valentina Natalucci; Giulia Baldelli; Mauro De Santi; Sabrina Donati Zeppa; Luciana Vallorani; Giosuè Annibalini; Francesco Lucertini; Ario Federici; Riccardo Izzo; Vilberto Stocchi; Elena Barbieri
Journal:  Oxid Med Cell Longev       Date:  2018-09-30       Impact factor: 6.543

9.  A Pilot Study of Influence of Endurance Training on the Prooxidative and Antioxidant Status of Women after Breast Cancer.

Authors:  Katarzyna Domaszewska; Arkadiusz Janiak; Tomasz Podgórski; Anna Demuth; Jakub Kryściak; Paweł Perkowski; Urszula Czerniak
Journal:  Int J Environ Res Public Health       Date:  2021-03-10       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.